SACRX
Price
$9.73
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
VGSNX
Price
$21.53
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

SACRX vs VGSNX

Header iconSACRX vs VGSNX Comparison
Open Charts SACRX vs VGSNXBanner chart's image
Spirit of America Real Estate Inc&Gr C
Price$9.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.53
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SACRX vs VGSNX Comparison Chart
Loading...
VS
SACRX vs. VGSNX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SACRX is a Buy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. SACRX (78.3M). SACRX pays higher dividends than VGSNX: SACRX (8.91) vs VGSNX (4.01). SACRX was incepted earlier than VGSNX: SACRX (9 years) vs VGSNX (21 years). VGSNX is a more actively managed with annual turnover of: 9.00 vs. SACRX (4.00). SACRX has a lower initial minimum investment than VGSNX: SACRX (500) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.90 vs. SACRX (23.24). VGSNX return over 5 years is better than : 26.84 vs. SACRX (16.98).
SACRXVGSNXSACRX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years21 years-
Gain YTD13.68413.452102%
Front LoadN/AN/A-
Min. Initial Investment50050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets78.3M70.5B0%
Annual Yield % from dividends8.914.01222%
Returns for 1 year23.2426.9086%
Returns for 3 years0.133.644%
Returns for 5 years16.9826.8463%
Returns for 10 yearsN/A87.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics